Title: Full Text of HB2462
Official Title: 
Number of Sections: 1
Source: versions - House Amendment 001
Media Type: text/html

================================================================================

Section 1:
Full Text of HB2462 ILGA.GOV HB2462 - 104th General Assembly Rep. Maurice A. West, IIFiled: 3/13/2025   10400HB2462ham001LRB104 08649 BDA 23845 a1AMENDMENT TO HOUSE BILL 24622    AMENDMENT NO. ______. Amend House Bill 2462 by replacing 3everything after the enacting clause with the following: 4    "Section 5. The Epinephrine Injector Act is amended by 5changing Sections 5, 10, 15, and 20 and by adding Section 25 as 6follows: 7    (410 ILCS 27/5)8    Sec. 5. Definitions. As used in this Act:9    "Administer" means to directly apply an epinephrine 10delivery system injector to the body of an individual.11    "Authorized entity" means any entity or organization, 12other than a school covered under Section 22-30 of the School 13Code, in connection with or at which allergens capable of 14causing anaphylaxis may be present, including, but not limited 15to, independent contractors who provide student transportation 16to schools, recreation camps, colleges and universities, day   10400HB2462ham001- 2 -LRB104 08649 BDA 23845 a1care facilities, youth sports leagues, amusement parks, 2restaurants, sports arenas, and places of employment. The 3Department shall, by rule, determine what constitutes a day 4care facility under this definition.5    "Authorized individual" means an individual who has 6successfully completed the training program under Section 10 7of this Act. 8    "Department" means the Department of Public Health.9    "Epinephrine delivery system" means any form of 10epinephrine that is approved by the United States Food and 11Drug Administration, including any device that contains a dose 12of epinephrine, and that is used to administer epinephrine 13into the human body to prevent or treat a life-threatening 14allergic reaction. 15    "Epinephrine injector" includes an auto-injector approved 16by the United States Food and Drug Administration for the 17administration of epinephrine and a pre-filled syringe 18approved by the United States Food and Drug Administration and 19used for the administration of epinephrine that contains a 20pre-measured dose of epinephrine that is equivalent to the 21dosages used in an auto-injector. 22    "Health care practitioner" means a physician licensed to 23practice medicine in all its branches under the Medical 24Practice Act of 1987, a physician assistant under the 25Physician Assistant Practice Act of 1987 with prescriptive 26authority, or an advanced practice registered nurse with   10400HB2462ham001- 3 -LRB104 08649 BDA 23845 a1prescribing authority under Article 65 of the Nurse Practice 2Act.3    "Pharmacist" has the meaning given to that term under 4subsection (k-5) of Section 3 of the Pharmacy Practice Act.5    "Undesignated epinephrine injector" means an epinephrine 6injector prescribed in the name of an authorized entity.7(Source: P.A. 99-711, eff. 1-1-17; 100-513, eff. 1-1-18; 8100-799, eff. 1-1-19.) 9    (410 ILCS 27/10)10    Sec. 10. Prescription to authorized entity; use; training.11    (a) A health care practitioner may prescribe epinephrine 12injectors in the name of an authorized entity or authorized 13individual for use in accordance with this Act, and 14pharmacists and health care practitioners may dispense 15epinephrine delivery systems injectors pursuant to a 16prescription issued in the name of an authorized entity or 17authorized individual. Such prescriptions shall be valid for a 18period of 2 years.19    (a-1) A health care provider with prescribing authority 20who is employed by or under contract with the Department may 21issue a statewide standing order for the dispensing of 22epinephrine delivery systems for use under subsection (c) by 23authorized individuals or by employees or agents of authorized 24entities who have completed the training required by 25subsection (d).   10400HB2462ham001- 4 -LRB104 08649 BDA 23845 a1    (b) An authorized entity or authorized individual may 2acquire and stock a supply of undesignated epinephrine 3delivery systems injectors pursuant to a prescription issued 4under subsection (a) of this Section. Such undesignated 5epinephrine delivery systems injectors shall be stored in a 6location readily accessible in an emergency and in accordance 7with the instructions for use of the epinephrine delivery 8systems injectors. The Department may establish any additional 9requirements an authorized entity or authorized individual 10must follow under this Act.11    (c) An employee or agent of an authorized entity who is an 12authorized individual or any other individual who is an 13authorized individual has completed training under subsection 14(d) of this Section may:15        (1) anywhere allergens capable of causing anaphylaxis 16    may be present provide an epinephrine delivery system 17    injector to any individual on the property of the 18    authorized entity whom the employee, agent, or other 19    individual believes in good faith is experiencing 20    anaphylaxis, or to the parent, guardian, or caregiver of 21    such individual, for immediate administration, regardless 22    of whether the individual has a prescription for an 23    epinephrine delivery system injector or has previously 24    been diagnosed with an allergy; or25        (2) anywhere allergens capable of causing anaphylaxis 26    may be present administer an epinephrine delivery system   10400HB2462ham001- 5 -LRB104 08649 BDA 23845 a1    injector to any individual on the property of the 2    authorized entity whom the employee, agent, or other 3    individual believes in good faith is experiencing 4    anaphylaxis, regardless of whether the individual has a 5    prescription for an epinephrine delivery system injector 6    or has previously been diagnosed with an allergy.7    (d) An employee, agent, or other individual authorized 8must complete an anaphylaxis training program before he or she 9is able to provide or administer an epinephrine delivery 10system injector under this Section. Such training shall be 11valid for a period of 2 years and shall be conducted by a 12nationally recognized organization experienced in training 13laypersons in emergency health treatment. The Department shall 14include links to training providers' websites on its website.15    Training shall include, but is not limited to:16        (1) how to recognize signs and symptoms of an allergic 17    reaction, including anaphylaxis;18        (2) how to administer an epinephrine delivery system 19    injector; and20        (3) a test demonstrating competency of the knowledge 21    required to recognize anaphylaxis and administer an 22    epinephrine delivery system injector.23    Training may also include, but is not limited to:24        (A) a review of high-risk areas on the authorized 25    entity's property and its related facilities;26        (B) steps to take to prevent exposure to allergens;  10400HB2462ham001- 6 -LRB104 08649 BDA 23845 a1        (C) emergency follow-up procedures; and2        (D) other criteria as determined in rules adopted 3    pursuant to this Act.4    Training may be conducted either online or in person. The 5entity or individual conducting the training shall issue a 6certificate to each person who successfully completes the 7anaphylaxis training program. The Department shall approve 8training programs and list permitted training programs on the 9Department's Internet website.10(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19.) 11    (410 ILCS 27/15)12    Sec. 15. Costs. Whichever entity initiates the process of 13obtaining undesignated epinephrine delivery systems injectors 14and providing training to personnel for carrying and 15administering undesignated epinephrine delivery systems 16injectors shall pay for the costs of the undesignated 17epinephrine delivery systems injectors.18(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19.) 19    (410 ILCS 27/20)20    Sec. 20. Limitations. The use of an undesignated 21epinephrine delivery system injector in accordance with the 22requirements of this Act does not constitute the practice of 23medicine or any other profession that requires medical 24licensure.  10400HB2462ham001- 7 -LRB104 08649 BDA 23845 a1    Nothing in this Act shall limit the amount of epinephrine 2delivery systems injectors that an authorized entity or 3individual may carry or maintain a supply of.4(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19.) 5    (410 ILCS 27/25 new)6    Sec. 25. Liability limitation. An authorized individual 7who acts in good faith to provide or administer an epinephrine 8delivery system in an emergency situation pursuant to this 9Act, shall not, as a result of the authorized individual's 10acts, except for willful and wanton misconduct on the part of 11that individual, be liable for civil damages to a person to 12whom such epinephrine delivery system was given to or 13administered.".


================================================================================

Raw Text:
Full Text of HB2462 ILGA.GOV HB2462 - 104th General Assembly Rep. Maurice A. West, IIFiled: 3/13/2025   10400HB2462ham001LRB104 08649 BDA 23845 a1AMENDMENT TO HOUSE BILL 24622    AMENDMENT NO. ______. Amend House Bill 2462 by replacing 3everything after the enacting clause with the following: 4    "Section 5. The Epinephrine Injector Act is amended by 5changing Sections 5, 10, 15, and 20 and by adding Section 25 as 6follows: 7    (410 ILCS 27/5)8    Sec. 5. Definitions. As used in this Act:9    "Administer" means to directly apply an epinephrine 10delivery system injector to the body of an individual.11    "Authorized entity" means any entity or organization, 12other than a school covered under Section 22-30 of the School 13Code, in connection with or at which allergens capable of 14causing anaphylaxis may be present, including, but not limited 15to, independent contractors who provide student transportation 16to schools, recreation camps, colleges and universities, day   10400HB2462ham001- 2 -LRB104 08649 BDA 23845 a1care facilities, youth sports leagues, amusement parks, 2restaurants, sports arenas, and places of employment. The 3Department shall, by rule, determine what constitutes a day 4care facility under this definition.5    "Authorized individual" means an individual who has 6successfully completed the training program under Section 10 7of this Act. 8    "Department" means the Department of Public Health.9    "Epinephrine delivery system" means any form of 10epinephrine that is approved by the United States Food and 11Drug Administration, including any device that contains a dose 12of epinephrine, and that is used to administer epinephrine 13into the human body to prevent or treat a life-threatening 14allergic reaction. 15    "Epinephrine injector" includes an auto-injector approved 16by the United States Food and Drug Administration for the 17administration of epinephrine and a pre-filled syringe 18approved by the United States Food and Drug Administration and 19used for the administration of epinephrine that contains a 20pre-measured dose of epinephrine that is equivalent to the 21dosages used in an auto-injector. 22    "Health care practitioner" means a physician licensed to 23practice medicine in all its branches under the Medical 24Practice Act of 1987, a physician assistant under the 25Physician Assistant Practice Act of 1987 with prescriptive 26authority, or an advanced practice registered nurse with   10400HB2462ham001- 3 -LRB104 08649 BDA 23845 a1prescribing authority under Article 65 of the Nurse Practice 2Act.3    "Pharmacist" has the meaning given to that term under 4subsection (k-5) of Section 3 of the Pharmacy Practice Act.5    "Undesignated epinephrine injector" means an epinephrine 6injector prescribed in the name of an authorized entity.7(Source: P.A. 99-711, eff. 1-1-17; 100-513, eff. 1-1-18; 8100-799, eff. 1-1-19.) 9    (410 ILCS 27/10)10    Sec. 10. Prescription to authorized entity; use; training.11    (a) A health care practitioner may prescribe epinephrine 12injectors in the name of an authorized entity or authorized 13individual for use in accordance with this Act, and 14pharmacists and health care practitioners may dispense 15epinephrine delivery systems injectors pursuant to a 16prescription issued in the name of an authorized entity or 17authorized individual. Such prescriptions shall be valid for a 18period of 2 years.19    (a-1) A health care provider with prescribing authority 20who is employed by or under contract with the Department may 21issue a statewide standing order for the dispensing of 22epinephrine delivery systems for use under subsection (c) by 23authorized individuals or by employees or agents of authorized 24entities who have completed the training required by 25subsection (d).   10400HB2462ham001- 4 -LRB104 08649 BDA 23845 a1    (b) An authorized entity or authorized individual may 2acquire and stock a supply of undesignated epinephrine 3delivery systems injectors pursuant to a prescription issued 4under subsection (a) of this Section. Such undesignated 5epinephrine delivery systems injectors shall be stored in a 6location readily accessible in an emergency and in accordance 7with the instructions for use of the epinephrine delivery 8systems injectors. The Department may establish any additional 9requirements an authorized entity or authorized individual 10must follow under this Act.11    (c) An employee or agent of an authorized entity who is an 12authorized individual or any other individual who is an 13authorized individual has completed training under subsection 14(d) of this Section may:15        (1) anywhere allergens capable of causing anaphylaxis 16    may be present provide an epinephrine delivery system 17    injector to any individual on the property of the 18    authorized entity whom the employee, agent, or other 19    individual believes in good faith is experiencing 20    anaphylaxis, or to the parent, guardian, or caregiver of 21    such individual, for immediate administration, regardless 22    of whether the individual has a prescription for an 23    epinephrine delivery system injector or has previously 24    been diagnosed with an allergy; or25        (2) anywhere allergens capable of causing anaphylaxis 26    may be present administer an epinephrine delivery system   10400HB2462ham001- 5 -LRB104 08649 BDA 23845 a1    injector to any individual on the property of the 2    authorized entity whom the employee, agent, or other 3    individual believes in good faith is experiencing 4    anaphylaxis, regardless of whether the individual has a 5    prescription for an epinephrine delivery system injector 6    or has previously been diagnosed with an allergy.7    (d) An employee, agent, or other individual authorized 8must complete an anaphylaxis training program before he or she 9is able to provide or administer an epinephrine delivery 10system injector under this Section. Such training shall be 11valid for a period of 2 years and shall be conducted by a 12nationally recognized organization experienced in training 13laypersons in emergency health treatment. The Department shall 14include links to training providers' websites on its website.15    Training shall include, but is not limited to:16        (1) how to recognize signs and symptoms of an allergic 17    reaction, including anaphylaxis;18        (2) how to administer an epinephrine delivery system 19    injector; and20        (3) a test demonstrating competency of the knowledge 21    required to recognize anaphylaxis and administer an 22    epinephrine delivery system injector.23    Training may also include, but is not limited to:24        (A) a review of high-risk areas on the authorized 25    entity's property and its related facilities;26        (B) steps to take to prevent exposure to allergens;  10400HB2462ham001- 6 -LRB104 08649 BDA 23845 a1        (C) emergency follow-up procedures; and2        (D) other criteria as determined in rules adopted 3    pursuant to this Act.4    Training may be conducted either online or in person. The 5entity or individual conducting the training shall issue a 6certificate to each person who successfully completes the 7anaphylaxis training program. The Department shall approve 8training programs and list permitted training programs on the 9Department's Internet website.10(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19.) 11    (410 ILCS 27/15)12    Sec. 15. Costs. Whichever entity initiates the process of 13obtaining undesignated epinephrine delivery systems injectors 14and providing training to personnel for carrying and 15administering undesignated epinephrine delivery systems 16injectors shall pay for the costs of the undesignated 17epinephrine delivery systems injectors.18(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19.) 19    (410 ILCS 27/20)20    Sec. 20. Limitations. The use of an undesignated 21epinephrine delivery system injector in accordance with the 22requirements of this Act does not constitute the practice of 23medicine or any other profession that requires medical 24licensure.  10400HB2462ham001- 7 -LRB104 08649 BDA 23845 a1    Nothing in this Act shall limit the amount of epinephrine 2delivery systems injectors that an authorized entity or 3individual may carry or maintain a supply of.4(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19.) 5    (410 ILCS 27/25 new)6    Sec. 25. Liability limitation. An authorized individual 7who acts in good faith to provide or administer an epinephrine 8delivery system in an emergency situation pursuant to this 9Act, shall not, as a result of the authorized individual's 10acts, except for willful and wanton misconduct on the part of 11that individual, be liable for civil damages to a person to 12whom such epinephrine delivery system was given to or 13administered.".